3B BlackBio Dx Ltd.

BSE: 532067

Expensive Performer

Download real time

1761.05 -6.80 (-0.38%)

25.06% Fall from 52W High

3,574 BSE Volume

BSE 21 Mar, 2025 3:31 PM (IST)

1,511.5

Market Cap

Above industry Median

0.7

Beta 1Year

Very Low volatility

3B BlackBio Dx Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from 3B BlackBio Dx Ltd. on BSE

Search Inside the pdf :

3B BlackBio Dx Ltd.

22 Mar 2025, 04:51PM

1761.05

-0.38%

Company Update

3B BlackBio Dx Ltd - 532067 - Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations, 2011

BSE India

Disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011

3B BlackBio Dx Ltd.

14 Feb 2025

1761.05

-0.38%

Company Update

3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Advertisement clipping of Extract of the Unaudited Standalone and Consolidated Financial Results for the quarter and nine-months ended 31-12-2024

3B BlackBio Dx Ltd.

13 Feb 2025

1761.05

-0.38%

to see Rapid results content

3B BlackBio Dx Ltd.

13 Feb 2025

1761.05

-0.38%

Investor Presentation

3B BlackBio Dx Ltd - 532067 - Investor Presentation

BSE India

Investor Presentation

3B BlackBio Dx Ltd.

13 Feb 2025

1761.05

-0.38%

Corp. Note

3B BlackBio Dx Ltd - 532067 - Integrated Filing (Financial)

BSE India

Integrated filing (Financial) for the quarter and nine-months ended 31-12-2024

3B BlackBio Dx Ltd.

13 Feb 2025

1761.05

-0.38%

Result

3B BlackBio Dx Ltd - 532067 - Unaudited Standalone And Consolidated Financial Results For The Quarter …

BSE India

Unaudited Standalone and Consolidated Financial Results for the quarter and nine-months ended 31-12-24

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	28.41	32.58	20.30	-12.8%	40.0%
Operating Profit Qtr	15.07	16.18	8.87	-6.9%	69.9%
Net Profit Qtr	13.40	14.65	8.72	-8.5%	53.7%
Earning Per Share Adjusted latest Qtr	15.62	17.07	10.17	-8.5%	53.6%

* Consolidated data

Detailed Results

3B BlackBio Dx Ltd.

13 Feb 2025

1761.05

-0.38%

Board Meeting

3B BlackBio Dx Ltd - 532067 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Submission of Unaudited Standalone and Consolidated Financial Results for the quarter and nine-months ended 31-12-2024

3B BlackBio Dx Ltd.

03 Feb 2025

1761.05

-0.38%

Board Meeting

3B BlackBio Dx Ltd - 532067 - Board Meeting Intimation for Consideration And Approval Of The …

BSE India

3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on 31st December, 2024.

3B BlackBio Dx Ltd.

30 Jan 2025

1761.05

-0.38%

Company Update

3B BlackBio Dx Ltd - 532067 - Intimation Under Regulation 30 Of The SEBI (LODR) 2015

BSE India

Intimation under Regulation 30 of the SEBI (LODR) 2015

3B BlackBio Dx Ltd.

04 Jan 2025

1761.05

-0.38%

Company Update

3B BlackBio Dx Ltd - 532067 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Certificate under Reg 74 (5) of SEBI (DP) Regulations for the quarter ended December 31 , 2024

No results found

Is Kilpest India Ltd. worth buying?

207 Votes:

Buy 75.85%

Sell 16.43%

Hold 7.73%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >